Human Milk Glucose, Leptin, and Insulin Predict Cessation of Full Breastfeeding and Initiation of Formula Use
- PMID: 34348043
- PMCID: PMC8713450
- DOI: 10.1089/bfm.2021.0131
Human Milk Glucose, Leptin, and Insulin Predict Cessation of Full Breastfeeding and Initiation of Formula Use
Abstract
Objective: We aimed to investigate prospective associations between milk bioactives related to metabolic health (glucose, insulin, leptin, C reactive protein [CRP], and interleukin 6 [IL-6]) and incident formula initiation at 3 and 6 months postpartum. Design: This study included 363 mother-infant dyads who were fully breastfed at 1 month and participated in the prospective Mothers and Infants Linked for Healthy Growth study from pregnancy to 6 months postpartum. Associations between milk glucose, leptin, insulin, CRP, and IL-6 at 1 and 3 months and incident formula feeding (FF) at 3 and 6 months, respectively, were tested using multiple logistic regression, adjusting for numerous potential confounders such as maternal age and prepregnancy body mass index. Results: At 3 months postpartum, 1-month glucose (odds ratio [OR] 0.45 [95% confidence interval (CI): 0.27-0.75], p ≤ 0.01) and smaller decreases in glucose from 1 to 3 months (OR 0.51 [95% CI: 0.28-0.92], p = 0.03) were associated with lower odds of FF, whereas 1-month leptin (OR 2.30 [95% CI: 1.30-4.07], p < 0.01) and larger increase in insulin (OR 1.86 [95% CI: 1.23-2.81], p < 0.01) and leptin (OR 2.17 [95% CI: 1.29-3.68], p < 0.01) from 1 to 3 months were associated with increased odds of FF. At 6 months, insulin increases (OR 2.08 [95% CI: 1.03-4.17], p = 0.04) were associated with higher odds of FF. Conclusions: In a cohort of women with established lactation, 1-month milk glucose, insulin, and leptin predicted initiation of FF at 3 months. Early milk composition may provide a window into mammary gland function, allowing identification of women at risk of not meeting their breastfeeding goals.
Keywords: bioactives; breastfeeding; formula; human milk; infants; lactation; metabolic health.
Conflict of interest statement
D.R.J., D.A.F., L.H., E.O.K., and E.W.D. report grant funding from the National Institute of Child Health and Human Development (NICHD) during the conduct of this study. National Institute of Dental and Craniofacial Research (NIDCR). E.M.N. reports funding on a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). No other conflicts of interest or financial disclosures were reported.
Figures
References
-
- Eidelman AI, Schanler RJ. Breastfeeding and the use of human milk. Pediatrics 2012;129:e827–e841. - PubMed
-
- Victora CG, Bahl R, Barros AJD, et al. . Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet 2016;387:475–490. - PubMed
-
- Crowe SD, Hanley LE. Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol 2018;132:1086–1088. - PubMed
-
- PAHO/WHO. Guiding principles for complementary feeding of the breastfed child. Washington, DC: Pan American Health Organization/World Health Organization, 2002.
-
- Centers for Disease Control and Prevention. National Immunization Survey (NIS) Website. Available at https://www.cdc.gov/breastfeeding/data/nis_data/index.htm (accessed August 3, 2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
